Company Filing History:
2 out of 525 
1 out of 1 
1 out of 1 Years Active: 1992-1993
Title: The Innovative Contributions of Jean M Mencia-Huerta
Introduction
Jean M Mencia-Huerta is a notable inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly in the area of antibody production. With a total of 2 patents, his work has implications for therapeutic approaches in treating allergic conditions.
Latest Patents
Mencia-Huerta's latest patents include a method for inhibiting the production of IgE by using IL-9 inhibitors. This method focuses on the role of interleukin 9 in antibody production. Specifically, it describes how the production of IgG can be enhanced by administering a combination of interleukin 4 and interleukin 9 to either a subject or a cell culture. Additionally, the production of IgE is inhibited by administering an interleukin 9 inhibitor to a subject. These innovative methods highlight the potential for targeted therapies in managing immune responses.
Career Highlights
Throughout his career, Mencia-Huerta has worked with prestigious organizations such as the Ludwig Institute for Cancer Research Limited and the Department of Immunology at the Institut Henri Beaufour. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Mencia-Huerta has collaborated with esteemed colleagues, including Bernard Dugas and Catherine Druez. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
Jean M Mencia-Huerta's innovative work in immunology, particularly through his patents, showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in therapeutic strategies for allergic conditions.